ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.367,63
0,27%
Dow Jones
38.956,30
0,18%
Euro vs US Dollar
1,08045
-0,80%
Bitcoin
70.495,79
-0,38%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Clementia Pharmaceuticals Inc. (CMTA)

  7. Clementia Pharmaceuticals Inc. (CMTA) News

CMTA

Clementia Pharmaceuticals Inc. (CMTA)

Clementia Pharmaceuticals Inc.
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CMTA
DatumZeitQuelleÜberschriftSymbolFirma
15/08/201914h30GlobeNewswire Inc.Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s BoardNASDAQ:CMTAClementia Pharmaceuticals Inc.
29/04/201914h28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMTAClementia Pharmaceuticals Inc.
19/04/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201915h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201914h05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201914h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMTAClementia Pharmaceuticals Inc.
18/04/201914h02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
11/04/201918h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
11/04/201918h00GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
09/04/201918h40Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
09/04/201918h29GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
29/03/201922h09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CMTAClementia Pharmaceuticals Inc.
13/03/201914h02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
13/03/201912h24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201920h59PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201920h55PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201919h25PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201919h00PR Newswire (US)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
07/03/201919h00PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
06/03/201922h50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
06/03/201922h37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
06/03/201922h01PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
06/03/201922h01PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
01/03/201922h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMTAClementia Pharmaceuticals Inc.
01/03/201920h15PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Clementia Pharmaceuticals, Inc.NASDAQ:CMTAClementia Pharmaceuticals Inc.
28/02/201917h55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
26/02/201912h32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
26/02/201912h30GlobeNewswire Inc.Clementia Announces Cancellation of Fourth Quarter and Year-End 2018 Financial Results and Conference CallNASDAQ:CMTAClementia Pharmaceuticals Inc.
25/02/201922h26Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
25/02/201914h11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
 Showing the most relevant articles for your search:NASDAQ:CMTA

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
CCOM
US30
US 30
TG
BAYN
Bayer
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
FX
EURGBP
Euro vs Sterling
TG
D7G
Nel ASA
DBI
DAX
DAX
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten